You are currently viewing a new version of our website. To view the old version click .
  • Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
  • Article
  • Open Access

1 March 2006

The Mycolic Acids Analysis with Hplc Technique in Drug Susceptibility Testing of Mycobacterium Tuberculosis Strains †

,
and
Katedra i Klinika Chorób Wewnętrznych, Pneumonologii i Alergologii AM w Warszawie, Warsaw, Poland
*
Author to whom correspondence should be addressed.
Pracę wykonano w ramach realizacji projektu badawczego 2P05D00128 finansowanego przez Ministerstwo Nauki i Informatyzacji.

Abstract

The aim of this study was to evaluate the utility of the quantitative analysis of mycolic acids by HPLC technique in drug susceptibility testing of the M. tuberculosis isolates to the first-line antituberculous drugs: isoniazid and rifampicin. Drug susceptibility of the 30 clinical M.tbc isolates was examined by the mycolic acids analysis with HPLC technique and results were compared to the proportion method on solid L-J medium and liquid medium in MGIT system. In HPLC method drug susceptibility of M. tuberculosis strains was described by TAMA index defined as the ratio of thetotal area under mycolic acids peaks (TAMA) from cultures with drug to the TAMA of control. At critical concentrations of drugs, TAMA indexes of resistant strains were >0.5, and TAMA indexes of susceptible strains were <0.05. The average error of the TAMA analysis was ±9.5% The quantitative analysis of mycolic acids by HPLC gives results compatible with standard proportion method and is a reliable method for determination of drug susceptibility of M. tuberculosis.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.